Cargando…

Comparing active treatments at phase II: using multiple criteria to find the optimal treatment to take forward to phase III

Detalles Bibliográficos
Autores principales:	Sweeting, Michael, Law, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981626/ http://dx.doi.org/10.1186/1745-6215-14-S1-O117

Ejemplares similares

Using meta-analysis of Phase II trials to predict Phase III trial results
por: Burke, Danielle, et al.
Publicado: (2013)

A series of decision-theoretic phase II trials of related treatments
por: Hee, Siew Wan, et al.
Publicado: (2013)

An adaptive seamless phase II/III clinical trial design incorporating short-term endpoint information
por: Stallard, Nigel
Publicado: (2011)

Alternatives to inpatient treatment in the acute phase
por: Hauth, Iris
Publicado: (2007)

A Bayesian dose-finding procedure applied to a seamless phase I/II trial in rheumatoid arthritis
por: Whitehead, Anne, et al.
Publicado: (2011)

DESIGN OF THE MYECHILD TRIAL, AN INTERNATIONAL RANDOMISED PHASE III CLINICAL TRIAL IN CHILDREN WITH ACUTE MYELOID LEUKAEMIA INCORPORATING AN EMBEDDED DOSE FINDING STUDY
por: Houlton, Aimee, et al.
Publicado: (2015)

A framework for the design and analysis of phase III randomised trials in uncommon diseases
por: Parmar, Mahesh, et al.
Publicado: (2015)

Efficient design of a phase III trial of competing tests for personalised cancer treatment in the absence of gold standard outcome data: challenges and potential solutions
por: Hall, Peter, et al.
Publicado: (2013)

Pooled week 48 safety and efficacy results from the ECHO and THRIVE phase III trials comparing TMC278 vs EFV in treatment-naïve, HIV-1-infected patients
por: Cohen, C, et al.
Publicado: (2010)

Combining pharmacophore- and MD-based modelling for phase II metabolism prediction
por: Rakers, Christin, et al.
Publicado: (2014)

Comparison of a frequentist and Bayesian response-adaptive randomisation approach in multi-stage phase II selection trials with multiple experimental arms
por: Yap, Christina, et al.
Publicado: (2015)

Pre-clinical validation of a humanized anti-EGFR variant III chimeric antigen receptor and phase I trial of CART-EGFRvIII in glioblastoma
por: Johnson, Laura A, et al.
Publicado: (2014)

The design of a multi-arm multi-stage (MAMS) phase III randomised controlled trial comparing alternative regimens for escalating (COMPARE) treatment of intermediate and high-risk oropharyngeal cancer with reflections on the complications of introducing a new experimental ARM
por: Gaunt, Piers, et al.
Publicado: (2015)

Design choices for small-scale phase II trials with non-inferiority (NI) intention
por: Sun, Hong, et al.
Publicado: (2011)

Using continuous data on tumour measurements to improve inference in phase II cancer studies
por: Wason, James, et al.
Publicado: (2013)

The safety of multiple oral immunotherapy in phase one studies at a single center
por: Dominguez, TLR, et al.
Publicado: (2013)

Screened selection design for randomised phase II oncology trials: an example in chronic lymphocytic leukaemia
por: Yap, Christina, et al.
Publicado: (2011)

Phase II investigation of a PARP inhibitor (olaparib) in castration resistant prostate cancer (CRPC) which incorporates the possibility that treatment effect may be restricted to biomarker defined subgroups
por: A’Hern, Roger, et al.
Publicado: (2011)

Implementation of adaptive dose-finding designs in two early phase haematological trials: clinical, operational, and methodological challenges
por: Yap, Christina, et al.
Publicado: (2013)

Modelling phase precession in the hippocampus
por: Chadwick, Angus, et al.
Publicado: (2015)

Rate of surgery in patients under treatment with a Chêneau light brace using the SRS inclusion criteria
por: Werkmann, M, et al.
Publicado: (2012)

Efficacy of conservative treatment of adolescent idiopathic scoliosis: end-growth results respecting SRS and SOSORT criteria
por: Negrini, S, et al.
Publicado: (2009)

Design of RESILIENCE: a phase 3 trial comparing capecitabine in combination with sorafenib or placebo for treatment of locally advanced or metastatic HER2-negative breast cancer
por: Baselga, J, et al.
Publicado: (2011)

Using Multiple Criteria Decision Analysis (MCDA) to make coverage decisions: a methodological framework
por: Kanavos, Panos, et al.
Publicado: (2015)

Efficiency gains resulting from the ordinal analysis of a functional outcome scale: a case study of a major phase III stroke trial
por: Murray, Gordon D, et al.
Publicado: (2011)

Phase 2, open-label extension (OLE) study of revusiran, an investigational RNAi therapeutic for the treatment of patients with transthyretin cardiac amyloidosis
por: Gillmore, Julian D, et al.
Publicado: (2015)

Biomarker analysis of on-treatment and at progression biopsies from BRIM7 - a phase 1B trial of combined vemurafenib and cobimetinib treatment in BRAF V600 mutated melanoma
por: Yan, Yibing, et al.
Publicado: (2014)

Bt technology -the way forward
por: Valicente, Fernando
Publicado: (2014)

A Phase I trial of B-cell depletion with anti-CD20 monoclonal antibody (rituximab) in the treatment of systemic lupus erythematosus
por: Eisenberg, R, et al.
Publicado: (2003)

Preliminary results from a Phase I/II study of epacadostat (incb024360) in combination with pembrolizumab in patients with selected advanced cancers
por: Gangadhar, Tara C, et al.
Publicado: (2015)

Finding modifiable predictors of treatment dropout: the role of the therapeutic alliance, readiness to change and acceptance of treatment approach
por: Pannekoek, Louise, et al.
Publicado: (2015)

Applying Multiple Criteria Decision Analysis (MCDA) in the context of HTA: an experimental case study on metastatic colorectal cancer
por: Angelis, Aris, et al.
Publicado: (2015)

Multiple antibody specificities (gp41, V1V2, and V3) elicited in the phase II multiclade (A, B, C) HIV-1 DNA prime, rAd5 boost vaccine trial
por: Williams, WB, et al.
Publicado: (2012)

Fast Forward. People development in Africa
por: van Buuren, Abré, et al.
Publicado: (2014)

Adaptive dose-finding designs to identify multiple doses that achieve multiple response targets
por: Bond, Simon, et al.
Publicado: (2013)

Intra-operative high intensity focused ultrasound in patients with colorectal liver metastases: results of a phase I-II study in 21 patients
por: Melodelima, David, et al.
Publicado: (2015)

Brace treatment in juvenile idiopathic scoliosis: a prospective study with outcomes in agreement with SRS committee on bracing and nonoperative management standardization criteria
por: Gabriele, Aulisa Angelo, et al.
Publicado: (2013)

Outcome of Rigo-Chêneau type brace treatment for adolescent idiopathic scoliosis - using the Scoliosis Research Society brace studies inclusion criteria
por: Maruyama, T, et al.
Publicado: (2013)

OA04-06 LB. Post-infection cellular immune responses in recipients following ALVAC-HIV® + AIDSVAX® B/E prime-boost vaccination in the Thai Phase III Trial
por: Kim, JH, et al.
Publicado: (2009)

Are patients fulfilling MET criteria recognized?
por: Hesselfeldt, R, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_lk83tepubgt0pt55ers4u1ktqk